Men taking cholesterol-lowering medication may be less likely to get prostate cancer than those not on the drugs, suggests a new study. They are also less likely to wind up with aggressive versions of the disease, researchers found.The finding can’t prove that the drugs, called statins, lower the risk of prostate cancer, and the authors note that there is still some controversy about if and how statins affect a man’s chance of getting prostate cancer.
